Cancer Research and Treatment10.4143/crt.2021.0102022541259-268Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with NeuroblastomaJi Won Lee, Joon Seol Bae, Jin Ho Kim, Hee Won Cho, Hee Young Ju, Keon Hee Yoo, Hong Hoe Koo, Sook-young Woo, Seonwoo Kim, Ki Woong Sung,,
Breast Cancer Research10.1186/bcr618200355First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation studyEdgardo Rivera, M Haim Erder, Moshe Fridman, Debra Frye, Gabriel N Hortobagyi,,
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY10.24293/ijcpml.v21i3.12692018213215-219ANALISIS ABSOLUTE NEUTROPHIL COUNT DI PASIEN KANKER PAYUDARA DENGAN KEMOTERAPI (Analysis of Absolute Neutrophil Count in Breast Cancer Patients with Chemotherapy)Arifa Moidady, Tenri Esa, Uleng Bahrun,
Pharmacotherapy10.1592/phco.27.10.1387200727101387-1393Serum Pegfilgrastim Concentrations During Recovery of Absolute Neutrophil Count in Patients with Cancer Receiving Pegfilgrastim After ChemotherapyBing-Bing Yang, Anna Kido, Atsuko Shibata,
Journal of Cancer Therapy10.4236/jct.2014.5202120140502172-178First Cycle Neutrophil Count and Subsequent Chemotherapy Dose Delivery in Breast Cancer Patients Receiving Adjuvant ChemotherapyAhmed Ashour, Gamal El-Husseiny, Amr Abdel Aziz, Waleed O. Arafat,,
Respirology10.1111/resp.14150_331202126S3208-208P5‐124: Analysis of chemotherapy history and absolute neutrophil count to antibody antimannan in lung cancer patients with candidiasis,,
Journal of Physics: Conference Series10.1088/1742-6596/884/1/0120292017884012029Body weight, hemoglobin, and absolute neutrophil count in patients with advanced-stage epithelial ovarian cancer who received chemotherapy: A single-center studyY Gunawan, H Winarto,,,
Asia-Pacific Journal of Clinical Oncology10.1111/ajco.133252020164247-253Neutrophil count kinetics during the first cycle of chemotherapy predicts the outcome of patients with locally advanced or metastatic pancreatic cancerGiuseppe Antonio Colloca, Antonella Venturino, Domenico Guarneri,,,
Chemotherapy10.1159/0005070432019645-6259-269Utility of the Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio for Predicting Survival in Patients with Metastatic Breast Cancer on Eribulin: A Real-World Observational StudyAyako Ueno, Reina Maeda, Takanori Kin, Mitsuya Ito, Kensuke Kawasaki, Shoichiro Ohtani,
10.21203/ Lymphocyte Count as a Surrogate Marker of Immune Checkpoint Inhibitor Therapy Outcomes in Patients with Non-Small-Cell Lung CancerYe Jin Lee, Young Sik Park, Hyun Woo Lee, Tae Yun Park, Jung Kyu Lee, Eun Young Heo,